Filing Details

Accession Number:
0001209191-12-028594
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-16 13:00:00
Reporting Period:
2012-05-15
Filing Date:
2012-05-16
Accepted Time:
2012-05-16 16:35:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1349077 Lisa Kelly C/O Vertex Pharmaceuticals Incorporated
130 Waverly St
Cambridge MA 02139
Svp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-05-15 37 $65.24 23,255 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.